Readystate Asset Management LP Amgen Inc Call Options Transaction History

Readystate Asset Management LP

  • $3.08 Trillion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$262.75 - $319.31 $7.07 Million - $8.59 Million
-26,900 Reduced 93.73%
1,800 $562 Million
Q1 2024

May 10, 2024
BUY
$268.87 - $324.56 $7.23 Million - $8.73 Million
26,900 Added 1494.44%
28,700 $8.16 Billion
Q4 2023

Feb 14, 2024
BUY
$255.7 - $288.46 $127,850 - $144,230
500 Added 38.46%
1,800 $518 Million
Q2 2023

Aug 14, 2023
BUY
$214.27 - $253.37 $278,551 - $329,381
1,300 New
1,300 $289 Million

Others Institutions Holding AMGN

# of Institutions
3,080
Shares Held
417M
Call Options Held
7.19M
Put Options Held
6.28M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Readystate Asset Management LP Portfolio

Follow Readystate Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Readystate Asset Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email